SCHEMBL5016325

SCHEMBL5016325

CC(=O)C(C)c1ccccc1CC(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.47
GABRB2 P47870 1/20 0.47
PTGS2 P35354 4/20 0.41
PTGS1 P23219 3/20 0.41
LMNA P02545 2/20 0.41
CYP2C9 P11712 2/20 0.41
AKR1C3 P42330 2/20 0.41
CXCR1 P25024 2/20 0.41
CXCR2 P25025 2/20 0.41
ALOX5 P09917 2/20 0.41
ALB P02768 1/20 0.41
ESR1 P03372 1/20 0.41
RARB P10826 1/20 0.41
ADRB3 P13945 1/20 0.41
NFKB1 P19838 1/20 0.41
HTR2A P28223 1/20 0.41
NR1I3 Q14994 1/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
CXCL8 P10145 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4483212 1.00 GABRA1 (0.47) GABRA1GABRB2PTGS2PTGS1LMNA
SCHEMBL4480628 1.00 GABRA1 (0.47) GABRA1GABRB2PTGS2PTGS1LMNA
SCHEMBL1394339 0.89 PTGS2 (0.49) GABRA1GABRB2PTGS2PTGS1LMNA
SCHEMBL9119656 0.89 PTGS2 (0.49) GABRA1GABRB2PTGS2PTGS1LMNA
SCHEMBL3155111 0.89 PTGS2 (0.49) GABRA1GABRB2PTGS2PTGS1LMNA
SCHEMBL6280689 0.84 EPHX1 (0.50) GABRA1GABRB2CXCL8EPHX1
SCHEMBL6284224 0.84 EPHX1 (0.50) GABRA1GABRB2CXCL8EPHX1
SCHEMBL27503669 0.84 GABRA1 (0.46) GABRA1GABRB2PTGS2PTGS1LMNA
SCHEMBL15253448 0.80 TSHR (0.43) GABRA1GABRB2LMNATSHR
SCHEMBL5017117 0.80 GABRA1 (0.42) GABRA1GABRB2PTGS2PTGS1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581474-B1 CHIRAL ARYLKETONES IN THE TREATEMENT OF NEUTROPHIL-DEPENDENT INFLAMMATORY DESEASES DOMPE SPA (IT) 2008-08-27 EP claimed
EP-1581474-B1 CHIRAL ARYLKETONES IN THE TREATEMENT OF NEUTROPHIL-DEPENDENT INFLAMMATORY DESEASES DOMPE SPA (IT) 2008-08-27 EP disclosed
EP-1581474-A1 CHIRAL ARYLKETONES IN THE TREATEMENT OF NEUTROPHIL-DEPENDENT INFLAMMATORY DESEASES Dompé S.P.A. (IT) 2005-10-05 EP disclosed
WO-2004052830-A1 CHIRAL ARYLKETONES IN THE TREATEMENT OF NEUTROPHIL-DEPENDENT INFLAMMATORY DESEASES DOMPE S.P.A. (IT) 2004-06-24 WO disclosed